Company Info
Knight Therapeutics Inc. is a Canadian-based specialty pharmaceutical company that focuses on acquiring, licensing, and commercializing innovative prescription medications and over-the-counter products primarily for the Latin American and Canadian markets. Established in 2014, the company aims to address unmet medical needs by providing high-quality pharmaceutical solutions. Knight Therapeutics is known for its robust portfolio, which spans various therapeutic areas, and its strategic approach to partnerships and acquisitions. Headquartered in Montreal, the company is publicly traded on the Toronto Stock Exchange under the ticker symbol GUD.
Company Website